misleading statements

Class action lawsuit alleges Gartner executives made false statements about contract growth and consulting revenue, with stock plunging 27% in August 2025 and 21% in February 2026.

Class action lawsuit filed against $PSIX alleging false statements about data center market demand and manufacturing costs from May 2025 to March 2026.

Federal jury finds Elon Musk liable for misleading Twitter investors during $44B acquisition; potential $2.5B damages awarded.

Power Solutions International faces class action lawsuit alleging false statements about data center demand and manufacturing issues. Stock tumbled 19% and 29% following margin misses.

Rosen Law Firm files securities class action against $CIGL, alleging fraudulent promotion, insider dumping, and false disclosures between April-July 2025.

Law firm files class action against $PSIX over alleged false statements about data center demand and manufacturing costs. Stock dropped sharply after earnings misses.

Robbins LLP files class action against Gartner for allegedly misrepresenting growth projections. Stock fell 21% after company disclosed weaker-than-expected contract value growth.

Securities lawsuit filed against $RGNX alleging misleading statements about RGX-111 gene therapy. Eligible investors must act before April 14, 2026 deadline.

Securities fraud lawsuit filed against Alight (ALIT) alleges executives misrepresented growth and sales execution while stock collapsed 56% over 15 months.

Law firm investigates securities fraud claims against ASP Isotopes, Integer Holdings, Molina Healthcare, and Soleno Therapeutics for alleged misstatements regarding technology, competitive position, medical costs, and drug safety.

Ramaco Resources faces class action over allegedly misleading statements about Brook Mine operations. Lead plaintiff deadline set for March 31, 2026.

The Gross Law Firm launches shareholder alert for $ORCL securities lawsuit alleging false statements on AI infrastructure spending without proportional revenue growth.

The Gross Law Firm launched a shareholder class action against BellRing Brands (BRBR), alleging misleading statements about sales growth and competitive pressures from November 2024 to August 2025.

Gemini Space Station Inc. ($GEMI) sued for securities violations over allegedly false IPO statements regarding crypto platform viability and international expansion plans.

UniQure faces securities fraud lawsuit alleging false FDA approval and BLA timeline claims. Investors in stock between September-October 2025 can join class action by April 2026 deadline.

uniQure faces class action lawsuit alleging misleading statements about pivotal study design and FDA approval prospects. Shareholders have until April 13, 2026 to join.

Apollo Global Management ($APO) stock plunged 15% after revelations of undisclosed business dealings with Jeffrey Epstein, triggering a securities class action lawsuit against CEO Marc Rowan.

Schall Law Firm files class action against Gemini Space Station Inc. ($GEMI) alleging false statements about crypto platform viability and overstated expansion prospects.

Hagens Berman investigates $QURE for misrepresenting FDA interactions on gene therapy AMT-130. Stock crashed 49% after FDA publicly rebuked company's data claims.

Corcept Therapeutics faces class action lawsuit for allegedly misrepresenting FDA trial data; stock collapsed 50% after regulatory rejection of relacorilant drug.